Pneumology - Original Articles Open access

Prevalence and characteristics of venous thromboembolism in severe exacerbation of chronic obstructive pulmonary disease in a tertiary care hospital in India

Authors

Published
16 March 2021
Section
Pneumology - Original Articles
DOI
10.4081/monaldi.2021.1742

Abstract

Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) carries a high risk of venous thromboembolism (VTE). Pulmonary embolism (PE) and AECOPD increase the mortality and morbidity risk associated with each other. Racial and ethnic differences in VTE risk have been documented in multiple studies. However, there is a dearth of reliable Indian data on the same. This study was planned to find the prevalence of VTE in the setting of severe AECOPD in a tertiary care hospital in India and to identify the clinical, laboratory and radiological characteristics of VTE in severe AECOPD. A total of 156 consecutive patients admitted with severe AECOPD and meeting the specified inclusion and exclusion criteria were recruited. Thorough workup of all patients was done including ABG, serum D dimer, ECG, compression ultrasound of lower limbs and 2-D echocardiography. Patients with high pre-test probability score, or intermediate pre-test probability score at presentation with serum D dimer above the age adjusted cut-off underwent computerised tomography pulmonary angiography (CTPA).  Results were analysed using SPSS version 23.  Sixteen (10.3%) patients had VTE, 15 (93.75%) of them being cases of isolated PE. Female gender, higher cumulative past exposure to corticosteroid, higher alveolar-arterial gradient, right ventricular dysfunction, and higher mean pulmonary artery pressure were associated with increased risk for VTE. The prevalence of VTE in AECOPD in this study among an Indian population is higher than among other Asians, but lower than among the Blacks, the Caucasians and the Middle-East ethnicities. Since a vast majority of VTE presents as PE without DVT in the setting of AECOPD, the absence of deep vein thrombosis of lower limbs does not rule PE in the setting.

Keywords

Supporting Agencies

All India Institute of Medical Sciences Rishikesh

References

  1. Shapira-Rootman M, Beckerman M, Soimu U, et al. The prevalence of pulmonary embolism among patients suffering
  2. from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol 2015;22:257–60. DOI: https://doi.org/10.1007/s10140-014-1280-7
  3. Aleva FE, Voets LWLM, Simons SO, et al. Prevalence and localization of pulmonary embolism in unexplained acute
  4. exacerbations of COPD: a systematic review and meta-analysis. Chest 2017;151:544–54. DOI: https://doi.org/10.1016/j.chest.2016.07.034
  5. Pineda LA, Hathwar VS, Grant BJ. Clinical suspicion of fatal pulmonary embolism. Chest 2001;120:791–5. DOI: https://doi.org/10.1378/chest.120.3.791
  6. Sidney S, Sorel M, Quesenberry CP, et al. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128:2068–75. DOI: https://doi.org/10.1378/chest.128.4.2068
  7. Saghazadeh A, Rezaei N. Inflammation as a cause of venous thromboembolism. Crit Rev Oncol Hematol 2016;99:272–85. DOI: https://doi.org/10.1016/j.critrevonc.2016.01.007
  8. Hurst JR, Perera WR, Wilkinson TMA, et al. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71–8. DOI: https://doi.org/10.1164/rccm.200505-704OC
  9. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353:1386–9. DOI: https://doi.org/10.1016/S0140-6736(98)07534-5
  10. Lesser B. The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease. Chest 1992:17–22. DOI: https://doi.org/10.1378/chest.102.1.17
  11. Tillie-Leblond I, Marquette C-H, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med 2006;144:390–6. DOI: https://doi.org/10.7326/0003-4819-144-6-200603210-00005
  12. White RH, Keenan CR. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009;123:S11-17. DOI: https://doi.org/10.1016/S0049-3848(09)70136-7
  13. Tran H. The risk of venous thromboembolism is lower in multiple Asian ethnic groups. Circulation 2018;137:AMP 18. DOI: https://doi.org/10.1161/circ.137.suppl_1.mp18
  14. Dutt TS, Udwadia ZF. Prevalence of venous thromboembolism in acute exacerbations of chronic obstructive pulmonary disease: an Indian perspective. Indian J Chest Dis Allied Sci 2011;53:207–10.
  15. Global Initiative for Obstructive Lung Disease. Accessed 8 Jan 2019. Available from: http://goldcopd.org/
  16. Raja AS, Greenberg JO, Qaseem A, et al. Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2015;163:701. DOI: https://doi.org/10.7326/M14-1772
  17. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients. Chest 2012;141:e195S-e226S. DOI: https://doi.org/10.1378/chest.11-2296
  18. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and expert panel report. Chest 2016;149:315–52. DOI: https://doi.org/10.1016/j.chest.2015.11.026
  19. Bertoletti L, Quenet S, Laporte S, et al. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry. Respir Res 2013;14:75. DOI: https://doi.org/10.1186/1465-9921-14-75
  20. Majoor CJ, Kamphuisen PW, Zwinderman AH, et al. Risk of deep vein thrombosis and pulmonary embolism in asthma. Eur Respir J 2013;42:655–61. DOI: https://doi.org/10.1183/09031936.00150312
  21. Bizien N, Noel-Savina E, Tromeur C, et al. Age is a major risk factor of venous thromboembolism (VTE). Eur Respir J 2011;38:3936.
  22. Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol 2019;4:163. DOI: https://doi.org/10.1001/jamacardio.2018.4537
  23. Martinez C, Cohen AT, Bamber L, et al. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer. Thromb Haemost 2014;112:255–63. DOI: https://doi.org/10.1160/TH13-09-0793
  24. Roach REJ, Cannegieter SC, Lijfering WM. Differential risks in men and women for first and recurrent venous thrombosis: the role of genes and environment. J Thromb Haemost 2014;12:1593–600. DOI: https://doi.org/10.1111/jth.12678
  25. Kwon YS, Choi W-I, Lee CW, et al. Sex difference of venous thromboembolism risk in chronic obstructive pulmonary disease and interstitial lung disease. Clin Exp Thromb Hemost 2017;3:24–30. DOI: https://doi.org/10.14345/ceth.17006
  26. Sørheim I-C, Johannessen A, Gulsvik A, et al. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax 2010;65:480–5. DOI: https://doi.org/10.1136/thx.2009.122002
  27. Maharana B, Ladusingh L. Gender disparity in health and food expenditure in India among elderly. Int J Popul Res 2014;2014:150105. DOI: https://doi.org/10.1155/2014/150105
  28. Cheng Y-J, Liu Z-H, Yao F-J, et al. Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med 2013;10:e1001515. DOI: https://doi.org/10.1371/journal.pmed.1001515
  29. Mahmoodi BK, Cushman M, Anne Næss I, et al. Association of traditional cardiovascular risk factors with venous thromboembolism: an individual participant data meta-analysis of prospective studies. Circulation 2017;135:7–16. DOI: https://doi.org/10.1161/CIR.0000000000000497
  30. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005;162:975–82. DOI: https://doi.org/10.1093/aje/kwi309
  31. Samuel S, Gomez L, Savarraj JP, et al. Assessment of the relationship between body mass index and incidence of venous thromboembolism in hospitalized overweight and obese patients. Pharmacotherapy 2017;37:893–9. DOI: https://doi.org/10.1002/phar.1953
  32. Deflandre E, Degey S, Opsomer N, et al. Obstructive sleep apnea and Smoking as a risk factor for venous thromboembolism events: review of the literature on the common pathophysiological mechanisms. Obes Surg 2016;26:640–8. DOI: https://doi.org/10.1007/s11695-015-2012-0
  33. Lippi G, Mattiuzzi C, Franchini M. Sleep apnea and venous thromboembolism. A systematic review. Thromb Haemost 2015;114:958–63. DOI: https://doi.org/10.1160/TH15-03-0188
  34. Erelel M, Çuhadaro Ǧ Ç, Ece T, et al. The frequency of deep venous thrombosis and pulmonary embolus in acute exacerbation of chronic obstructive pulmonary disease. Respir Med 2002;96:515–8. DOI: https://doi.org/10.1053/rmed.2002.1313
  35. Dong W, Zhu Y, Du Y, et al. Association between features of COPD and risk of venous thromboembolism. Clin Respir J 2019;13:499–504. DOI: https://doi.org/10.1111/crj.13051
  36. Squizzato A, Gerdes VEA, Ageno W, et al. The coagulation system in endocrine disorders: a narrative review. Intern Emerg Med 2007;2:76–83. DOI: https://doi.org/10.1007/s11739-007-0026-X
  37. Van Zaane B, Nur E, Squizzato A, et al. Hypercoagulable state in Cushing’s syndrome: a systematic review. J Clin Endocrinol Metab 2009;94:2743–50. DOI: https://doi.org/10.1210/jc.2009-0290
  38. Sneeboer MMS, Hutten BA, Majoor CJ, et al. Oral and inhaled corticosteroid use and risk of recurrent pulmonary embolism. Thromb Res 2016;140:46–50. DOI: https://doi.org/10.1016/j.thromres.2016.02.010
  39. Abdelghany. Can alveolar–arterial oxygen gradient predict severity of pulmonary embolism? Egypt J Bronchol 2019;13:273-9. DOI: https://doi.org/10.4103/ejb.ejb_62_18
  40. Cohoon KP, Ashrani AA, Crusan DJ, et al. Is infection an independent risk factor for venous thromboembolism? A population based case-control study. Am J Med 2018;131:307-316.e2. DOI: https://doi.org/10.1016/j.amjmed.2017.09.015
  41. Chan TC, Vilke GM, Pollack M, et al. Electrocardiographic manifestations: pulmonary embolism. J Emerg Med 2001;21:263-70. DOI: https://doi.org/10.1016/S0736-4679(01)00389-4
  42. Levis JT. ECG Diagnosis: pulmonary embolism. Perm J 2011;15:75. DOI: https://doi.org/10.7812/TPP/11-112
  43. Matthews JC, McLaughlin V. Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 2008;4:49–59. DOI: https://doi.org/10.2174/157340308783565384
  44. Günay E, Sarınç Ulaşlı S, Akar O, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation 2014;37:374–80. DOI: https://doi.org/10.1007/s10753-013-9749-1
  45. Furutate R, Ishii T, Motegi T, et al. The neutrophil to lymphocyte ratio is related to disease severity and exacerbation in patients with chronic obstructive pulmonary disease. Intern Med Tokyo Jpn 2016;55:223–9. DOI: https://doi.org/10.2169/internalmedicine.55.5772
  46. Paliogiannis P, Fois AG, Sotgia S, et al. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev 2018;27:170113. DOI: https://doi.org/10.1183/16000617.0113-2017
  47. Hogg K. CRP in the diagnosis of pulmonary embolism. Emerg Med J 2010;27:A4. DOI: https://doi.org/10.1136/emj.2010.103150.08
  48. Agarwal R, Zaheer MS, Ahmad Z, et al. The relationship between C-reactive protein and prognostic factors in chronic obstructive pulmonary disease. Multidiscip Respir Med 2013;8:63. DOI: https://doi.org/10.1186/2049-6958-8-63
  49. Gao D, Chen X, Wu H, et al. The levels of serum pro-calcitonin and high-sensitivity C-reactive protein in the early diagnosis of chronic obstructive pulmonary disease during acute exacerbation. Exp Ther Med 2017;14:193–8. DOI: https://doi.org/10.3892/etm.2017.4496

Author Biography

  • Ruchi Dua, Department of Pulmonary Medicine, All India Institute of Medical Sciences, Rishikesh

     

     

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2021 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.